Targeting CD74-positive macrophages improves neoadjuvant therapy in cervical cancer as revealed by single-cell transcriptomics analysis
Z. Wang, B. Wang, Y. Feng, J. Ye, Z. Mao, T. Zhang, M. Xu, W. Zhang, X. Jiao, Y. Zhang, B. Cui
This study uses single-cell transcriptomics to show that targeting CD74-positive macrophages enhances neoadjuvant therapy efficacy in cervical cancer by altering tumor microenvironment interactions.
bioRxiv · Nov 9, 2023 · PreprintCancer Biology